These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

974 related articles for article (PubMed ID: 17998447)

  • 1. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease.
    Walter U; Dressler D; Wolters A; Wittstock M; Benecke R
    Mov Disord; 2007 Jan; 22(1):48-54. PubMed ID: 17083096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
    Alonso-Canovas A; Tembl Ferrairó JI; Martínez-Torres I; Lopez-Sendon Moreno JL; Parees-Moreno I; Monreal-Laguillo E; Pérez-Torre P; Toledano Delgado R; García Ribas G; Sastre Bataller I; Masjuan J; Martinez-Castrillo JC; Walter U
    Parkinsonism Relat Disord; 2019 Nov; 68():40-45. PubMed ID: 31621617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes.
    Bouwmans AE; Vlaar AM; Srulijes K; Mess WH; Weber WE
    Int Rev Neurobiol; 2010; 90():121-46. PubMed ID: 20692498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
    Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
    Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease.
    Busse K; Heilmann R; Kleinschmidt S; Abu-Mugheisib M; Höppner J; Wunderlich C; Gemende I; Kaulitz L; Wolters A; Benecke R; Walter U
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):441-7. PubMed ID: 22362921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
    Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
    J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating progressive supranuclear palsy from other movement disorders using transcranial sonography: a systematic review and meta-analysis.
    Wen Y; Zhou H; Xia M; Liu Q; Quan H; Fang L
    Neurol Sci; 2024 Feb; 45(2):455-465. PubMed ID: 37819487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
    Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
    Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.
    Nicoletti G; Rizzo G; Barbagallo G; Tonon C; Condino F; Manners D; Messina D; Testa C; Arabia G; Gambardella A; Lodi R; Quattrone A
    Radiology; 2013 Jun; 267(3):843-50. PubMed ID: 23329659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesencephalic area measured by transcranial sonography in the differential diagnosis of parkinsonism.
    Sastre-Bataller I; Vázquez JF; Martínez-Torres I; Sahuquillo P; Rubio-Agustí I; Burguera JA; Ferrer JM; Valero C; Tembl JI
    Parkinsonism Relat Disord; 2013 Aug; 19(8):732-6. PubMed ID: 23684370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy.
    Walter U; Dressler D; Wolters A; Probst T; Grossmann A; Benecke R
    Neurology; 2004 Aug; 63(3):504-9. PubMed ID: 15304582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial brain sonography for Parkinsonian syndromes.
    Bor-Seng-Shu E; Paschoal FM; Almeida KJ; De Lima Oliveira M; Nogueira RC; Teixeira MJ; Walter U
    J Neurosurg Sci; 2019 Aug; 63(4):441-449. PubMed ID: 31210040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes.
    Walter U; Niehaus L; Probst T; Benecke R; Meyer BU; Dressler D
    Neurology; 2003 Jan; 60(1):74-7. PubMed ID: 12525721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound.
    Behnke S; Berg D; Naumann M; Becker G
    J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):423-5. PubMed ID: 15716540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transcranial sonography in Parkinson's disease].
    Fedotova EIu; Chechetkin AO; Shadrina MI; Slominskiĭ PA; Ivanova-Smolenskaia IA; Illarioshkin SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(1):49-55. PubMed ID: 21350412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcranial Brain Sonography in Parkinson's Disease and Other Parkinsonian Disorders: a Hospital Study from Tuzla, Bosnia and Herzegovina.
    Smajlovic D; Ibrahimagic OC
    Med Arch; 2017 Aug; 71(4):261-264. PubMed ID: 28974846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia Nigra Hyperechogenicity: Validation of Transcranial Sonography for Parkinson Disease Diagnosis in a Large Estonian Cohort.
    Toomsoo T; Liepelt-Scarfone I; Kerner R; Kadastik-Eerme L; Asser T; Rubanovits I; Berg D; Taba P
    J Ultrasound Med; 2016 Jan; 35(1):17-23. PubMed ID: 26589647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.